pJRH029 Citations (2)
Originally described in: Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering.Hamilton JR, Tsuchida CA, Nguyen DN, Shy BR, McGarrigle ER, Sandoval Espinoza CR, Carr D, Blaeschke F, Marson A, Doudna JA Cell Rep. 2021 Jun 1;35(9):109207. doi: 10.1016/j.celrep.2021.109207. PubMed Journal
Articles Citing pJRH029
| Articles |
|---|
| Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPs. Wichmann M, Maire CL, Nuppenau N, Habiballa M, Uhde A, Kolbe K, Schroder T, Lamszus K, Fehse B, Glow D. Int J Mol Sci. 2023 Jul 13;24(14):11399. doi: 10.3390/ijms241411399. PubMed |
In vivo human T cell engineering with enveloped delivery vehicles.
Hamilton JR, Chen E, Perez BS, Sandoval Espinoza CR, Kang MH, Trinidad M, Ngo W, Doudna JA.
Nat Biotechnol. 2024 Jan 11. doi: 10.1038/s41587-023-02085-z.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.